Americas Antibody Congress 2009. 21-23 September 2009, Washington DC, USA.
The Americas Antibody Congress 2009, held in Washington DC, included topics covering new state-of-the-art advances in antibody therapeutics. This conference report highlights selected presentations on enhanced antibody functionality, bispecific antibodies and antibody-drug conjugates. Technological approaches discussed include Potelligent technology from BioWa Inc, stability-engineered antibodies and BiTE antibodies.
Reyes
Christopher L
CL
Biogen Idec, 5200 Research Place, San Diego, CA 92122, USA. christopher.reyes@biogenidec.com
D000818:Animals; D018033:Antibodies, Bispecific / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology; D016503:Drug Delivery Systems; D015195:Drug Design; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000503:physiopathology
D018033:Antibodies, Bispecific; D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents